| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cellular immunity and active human cytomegalovirus infection in patients with septic shock.
|
J Infect Dis
|
2007
|
1.78
|
|
2
|
Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis.
|
Clin Infect Dis
|
2004
|
1.68
|
|
3
|
Telomerase gene mutations are associated with cirrhosis formation.
|
Hepatology
|
2011
|
1.67
|
|
4
|
Antiviral treatment of cytomegalovirus infection and resistant strains.
|
Expert Opin Pharmacother
|
2009
|
1.55
|
|
5
|
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation.
|
Transfusion
|
2010
|
1.49
|
|
6
|
Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant.
|
Leuk Lymphoma
|
2010
|
1.46
|
|
7
|
High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay.
|
J Clin Microbiol
|
2002
|
1.34
|
|
8
|
Cytomegalovirus primary envelopment occurs at large infoldings of the inner nuclear membrane.
|
J Virol
|
2006
|
1.34
|
|
9
|
Active cytomegalovirus infection in patients with septic shock.
|
Emerg Infect Dis
|
2006
|
1.28
|
|
10
|
A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes.
|
Antiviral Res
|
2009
|
1.13
|
|
11
|
Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages.
|
J Virol
|
2008
|
1.12
|
|
12
|
GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E.
|
Antiviral Res
|
2002
|
1.11
|
|
13
|
Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer.
|
J Virol
|
2004
|
1.11
|
|
14
|
Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration.
|
J Virol
|
2011
|
1.07
|
|
15
|
Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system.
|
Antiviral Res
|
2002
|
1.04
|
|
16
|
Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation.
|
Clin Infect Dis
|
2008
|
1.03
|
|
17
|
Inactivation and Environmental Stability of Zika Virus.
|
Emerg Infect Dis
|
2016
|
1.03
|
|
18
|
The tegument protein UL71 of human cytomegalovirus is involved in late envelopment and affects multivesicular bodies.
|
J Virol
|
2011
|
1.03
|
|
19
|
Constitutive inositol phosphate formation in cytomegalovirus-infected human fibroblasts is due to expression of the chemokine receptor homologue pUS28.
|
J Virol
|
2003
|
1.01
|
|
20
|
Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes.
|
J Biol Chem
|
2003
|
1.00
|
|
21
|
Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.
|
Clin Infect Dis
|
2010
|
0.99
|
|
22
|
The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host.
|
Biochim Biophys Acta
|
2004
|
0.99
|
|
23
|
Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation.
|
J Virol
|
2012
|
0.99
|
|
24
|
Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.
|
J Virol
|
2013
|
0.98
|
|
25
|
Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.
|
PLoS One
|
2011
|
0.98
|
|
26
|
Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation.
|
J Virol
|
2005
|
0.98
|
|
27
|
TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections.
|
Gastroenterology
|
2002
|
0.98
|
|
28
|
Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein-coupled receptor.
|
J Biol Chem
|
2002
|
0.97
|
|
29
|
Differentiation between polymorphisms and resistance-associated mutations in human cytomegalovirus DNA polymerase.
|
Antimicrob Agents Chemother
|
2010
|
0.96
|
|
30
|
Human cytomegalovirus-induced reduction of extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in vasculopathies?
|
J Gen Virol
|
2006
|
0.96
|
|
31
|
Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus.
|
J Gen Virol
|
2005
|
0.95
|
|
32
|
Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir.
|
Mol Pharmacol
|
2002
|
0.91
|
|
33
|
Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy.
|
J Clin Immunol
|
2004
|
0.91
|
|
34
|
Fatal reactivation of postnatal cytomegalovirus infection with rapid emergence of ganciclovir resistance in an infant after allogeneic stem cell transplantation.
|
J Clin Microbiol
|
2005
|
0.91
|
|
35
|
Fluorescence-based assay for phenotypic characterization of human cytomegalovirus polymerase mutations regarding drug susceptibility and viral replicative fitness.
|
Antimicrob Agents Chemother
|
2009
|
0.91
|
|
36
|
Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group.
|
Atherosclerosis
|
2003
|
0.90
|
|
37
|
Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor.
|
J Immunol
|
2009
|
0.90
|
|
38
|
HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor.
|
Cardiovasc Res
|
2005
|
0.90
|
|
39
|
The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system.
|
J Gen Virol
|
2005
|
0.90
|
|
40
|
Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment.
|
J Virol
|
2006
|
0.90
|
|
41
|
Human cytomegaloviruses expressing yellow fluorescent fusion proteins--characterization and use in antiviral screening.
|
PLoS One
|
2010
|
0.89
|
|
42
|
Quantitative investigation of murine cytomegalovirus nucleocapsid interaction.
|
J Microsc
|
2007
|
0.87
|
|
43
|
Improved detection of mutated human cytomegalovirus UL97 by pyrosequencing.
|
Antimicrob Agents Chemother
|
2010
|
0.87
|
|
44
|
Cytomegalovirus primary envelopment at large nuclear membrane infoldings: what's new?
|
J Virol
|
2007
|
0.85
|
|
45
|
CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients.
|
Br J Haematol
|
2004
|
0.85
|
|
46
|
Analysis of human cytomegalovirus secondary envelopment by advanced electron microscopy.
|
Cell Microbiol
|
2012
|
0.84
|
|
47
|
Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study.
|
Clin Infect Dis
|
2008
|
0.84
|
|
48
|
Opinion article: cytomegalovirus is a risk factor in atherogenesis.
|
Herpes
|
2002
|
0.83
|
|
49
|
Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation.
|
J Med Virol
|
2006
|
0.82
|
|
50
|
Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient.
|
BMC Infect Dis
|
2013
|
0.82
|
|
51
|
The 7-transmembrane protein homologue UL78 of the human cytomegalovirus forms oligomers and traffics between the plasma membrane and different intracellular compartments.
|
Arch Virol
|
2012
|
0.82
|
|
52
|
Effective disinfection of orthodontic pliers.
|
J Orofac Orthop
|
2006
|
0.82
|
|
53
|
Nuclear targeting of human cytomegalovirus large tegument protein pUL48 is essential for viral growth.
|
J Virol
|
2013
|
0.81
|
|
54
|
The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
|
J Immunol
|
2011
|
0.81
|
|
55
|
Human cytomegalovirus infection in human renal arteries in vitro.
|
J Virol Methods
|
2003
|
0.80
|
|
56
|
Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression.
|
Med Microbiol Immunol
|
2008
|
0.79
|
|
57
|
Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
|
Antimicrob Agents Chemother
|
2005
|
0.79
|
|
58
|
Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010.
|
Vaccine
|
2011
|
0.79
|
|
59
|
Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation.
|
BMC Infect Dis
|
2013
|
0.78
|
|
60
|
Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease.
|
BMC Cardiovasc Disord
|
2005
|
0.78
|
|
61
|
Assessment of natural killer cell responses to human cytomegalovirus-infected macrophages.
|
Methods Mol Biol
|
2013
|
0.78
|
|
62
|
HCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasia.
|
BMC Microbiol
|
2007
|
0.78
|
|
63
|
Treatment of chronic hepatitis B with high-dose intravenous N-acetyl-L-cysteine.
|
Hepatogastroenterology
|
2003
|
0.77
|